Found: 16
Select item for more details and to access through your institution.
Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1154377
- By:
- Publication type:
- Article
Ruxolitinib after fedratinib failure in patients with myelofibrosis: A real‐world case series.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 4, p. 1605, doi. 10.1111/bjh.19654
- By:
- Publication type:
- Article
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology.
- Published in:
- Oncogene, 2015, v. 34, n. 26, p. 3482, doi. 10.1038/onc.2015.191
- By:
- Publication type:
- Article
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology.
- Published in:
- Oncogene, 2014, v. 33, n. 22, p. 2876, doi. 10.1038/onc.2013.251
- By:
- Publication type:
- Article
The impact of comorbidity on health-related quality of life in elderly patients with chronic myeloid leukemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
What is the optimal dosage of valganciclovir as preemptive therapy for CMV infection in allogeneic hematopoietic SCT?
- Published in:
- 2008
- By:
- Publication type:
- Letter
Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Imatinib mesylate (Glivec) pre-treatment does not have a negative effect on outcome of allogenic hematopoietic stem cell transplantation in Philadelphia-positive leukemias.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study.
- Published in:
- British Journal of Cancer, 2012, v. 107, n. 6, p. 904, doi. 10.1038/bjc.2012.348
- By:
- Publication type:
- Article
Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia.
- Published in:
- Annals of Hematology, 2002, v. 81, n. 8, p. 462, doi. 10.1007/s00277-002-0509-9
- By:
- Publication type:
- Article
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia.
- Published in:
- 2010
- By:
- Publication type:
- Letter
WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia.
- Published in:
- Leukemia (08876924), 2007, v. 21, n. 7, p. 1442, doi. 10.1038/sj.leu.2404670
- By:
- Publication type:
- Article
Two novel NPM1 mutations in a therapy-responder AML patient.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Myeloid Sarcoma: The Clinician's Point of View.
- Published in:
- Leukemia Research & Treatment, 2011, p. 1, doi. 10.4061/2011/410291
- By:
- Publication type:
- Article
Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy.
- Published in:
- 2012
- By:
- Publication type:
- journal article